-
1
Maxillary osteonecrosis linked to Pembrolizumab therapy: a case report
Published 2024-01-01Subjects: “…pembrolizumab…”
Get full text
Article -
2
Pembrolizumab for the Treatment of Locally Advanced Cutaneous Squamous Cell Carcinoma: Patient Selection and Special Considerations
Published 2025-02-01Subjects: Get full text
Article -
3
Case report: Low-dose radiation reverses pembrolizumab resistance in melanoma
Published 2025-02-01Subjects: Get full text
Article -
4
Toxicity Associated with Pembrolizumab Monotherapy in Patients with Gastrointestinal Cancers: A Systematic Review of Clinical Trials
Published 2025-01-01Subjects: “…pembrolizumab…”
Get full text
Article -
5
Efficacy and safety of pembrolizumab in patients with advanced endometrial cancer: a systematic review and meta-analysis
Published 2025-02-01Subjects: “…pembrolizumab…”
Get full text
Article -
6
-
7
Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherap...
Published 2025-02-01Subjects: “…pembrolizumab…”
Get full text
Article -
8
Pembrolizumab with external radiation therapy effectively controlled TMB-high unresectable recurrent parathyroid cancer: a case report with review of literature
Published 2024-11-01Subjects: “…pembrolizumab…”
Get full text
Article -
9
Successful Neoadjuvant Therapy with Pembrolizumab Monotherapy for Advanced Ascending Colon Cancer
Published 2023-07-01Subjects: Get full text
Article -
10
-
11
A case report of successful treatment of advanced thymic squamous cell carcinoma with poor performance status using multimodal therapy
Published 2025-01-01Subjects: Get full text
Article -
12
-
13
Identifying factors for pembrolizumab eligibility in head and neck cancer
Published 2025-02-01Subjects: “…Pembrolizumab…”
Get full text
Article -
14
Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50%
Published 2025-03-01Subjects: “…Pembrolizumab…”
Get full text
Article -
15
Clinical Use of Dostarlimab in Advanced Stage and Recurrent Endometrial Cancer: Patient Selection and Perspectives
Published 2025-01-01Subjects: Get full text
Article -
16
Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma
Published 2025-02-01Subjects: Get full text
Article -
17
Pembrolizumab- induced subacute cutaneous lupus erythematosus in a patient with oropharyngeal squamous cell carcinoma: A case report and literature review
Published 2025-12-01Subjects: “…Pembrolizumab…”
Get full text
Article -
18
Pembrolizumab plus Pemetrexed and Platinum in Metastatic Non-Squamous Non-Small Cell Lung Cancer: A Real-Life Study at a Portuguese Centre
Published 2025-02-01Subjects: Get full text
Article -
19